|
Market Closed -
Nasdaq
21:00:00 23/10/2026 BST
|
5-day change | 1st Jan Change | ||
| 14.26 USD | -2.79% |
|
-40.11% | - |
| 10-22 | Pharma sector doubles down on AI to slash costs, timelines | RE |
| 10-20 | Drug developer Lycia Therapeutics targets $938 million valuation in US IPO | RE |
Chart: Technical Analysis
NasdaqUSD
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| IAM | Delayed | |
CBOE
| IAM | Real-time |
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Bearish | Bearish | Bearish |
| Resistance | 18.43 | 18.43 | 18.43 |
| Spread/Res. | -22.63% | -22.63% | -22.63% |
| Spread/Supp. | +22.72% | +22.72% | +22.72% |
| Support | 11.62 | 11.62 | 11.62 |
- Stock Market
- Stocks
- IAM Stock
- Charts Iambic Therapeutics, Inc.
Select your edition
All financial news and data tailored to specific country editions
